These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 11231363

  • 1. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 2. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 3. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
    Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):268-74. PubMed ID: 10777713
    [Abstract] [Full Text] [Related]

  • 4. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H.
    Adv Otorhinolaryngol; 2011 Apr 29; 72():68-70. PubMed ID: 21865693
    [Abstract] [Full Text] [Related]

  • 5. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Hiki Y, Tanaka A, Kokubo T, Iwase H, Nishikido J, Hotta K, Kobayashi Y.
    J Am Soc Nephrol; 1998 Apr 29; 9(4):577-82. PubMed ID: 9555659
    [Abstract] [Full Text] [Related]

  • 6. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
    Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M.
    J Proteomics; 2013 Oct 30; 92():299-312. PubMed ID: 23891555
    [Abstract] [Full Text] [Related]

  • 7. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Oct 30; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 8. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 9. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy.
    Horie A, Hiki Y, Odani H, Yasuda Y, Takahashi M, Kato M, Iwase H, Kobayashi Y, Nakashima I, Maeda K.
    Am J Kidney Dis; 2003 Sep 22; 42(3):486-96. PubMed ID: 12955676
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y.
    J Nephrol; 2010 Sep 22; 23(1):70-6. PubMed ID: 20091489
    [Abstract] [Full Text] [Related]

  • 11. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S.
    Nephrol Dial Transplant; 2008 Jun 22; 23(6):1931-9. PubMed ID: 18178603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy.
    Allen AC.
    J Nephrol; 1999 Jun 22; 12(2):76-84. PubMed ID: 10378662
    [Abstract] [Full Text] [Related]

  • 15. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec 22; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 16. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
    Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.
    J Biol Chem; 2005 May 13; 280(19):19136-45. PubMed ID: 15728186
    [Abstract] [Full Text] [Related]

  • 17. Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
    Ohyama Y, Yamaguchi H, Nakajima K, Mizuno T, Fukamachi Y, Yokoi Y, Tsuboi N, Inaguma D, Hasegawa M, Renfrow MB, Novak J, Yuzawa Y, Takahashi K.
    Sci Rep; 2020 Jan 20; 10(1):671. PubMed ID: 31959827
    [Abstract] [Full Text] [Related]

  • 18. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Jan 20; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 19. IgA nephropathy and tonsils--an approach from the structure of IgA1 produced by tonsillar lymphocytes.
    Hiki Y, Horie A, Yasuda Y, Iwase H, Sugiyama S.
    Acta Otolaryngol Suppl; 2004 Dec 20; (555):28-31. PubMed ID: 15768794
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.